NASDAQ Composite opens in less than two hours and Inovio Pharmaceuticals‘s pre-market value is already 5.86% up.

The last session, NASDAQ Composite ended with Inovio Pharmaceuticals dropping 2.7% to $6.49. NASDAQ Composite fell 0.09% to $13,389.43, after two consecutive sessions in a row of losses, on what was a somewhat negative trend trading session.

Inovio Pharmaceuticals’s last close was $6.67, 420.65% under its 52-week high of $33.79.

Inovio Pharmaceuticals’s Sales

Inovio Pharmaceuticals’s sales growth is a negative 35.9% for the current quarter and 237.1% for the next. The company’s growth estimates for the ongoing quarter and the next is 30.8% and 77.1%, respectively.

Inovio Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth grew by 1896.7%, now sitting on 7.41M for the twelve trailing months.

Inovio Pharmaceuticals’s Stock Yearly Top and Bottom Value

Inovio Pharmaceuticals’s stock is valued at $6.49 at 08:11 EST, way under its 52-week high of $33.79 and way higher than its 52-week low of $5.81.

Inovio Pharmaceuticals’s Moving Average

Inovio Pharmaceuticals’s worth is way below its 50-day moving average of $10.61 and way below its 200-day moving average of $11.28.


Inovio Pharmaceuticals’s last day, last week, and last month’s current volatility was 2.70%, 2.01%, and 3.79%, respectively.

Inovio Pharmaceuticals’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 8.93% (day), 5.44% (last week), and 6.20% (last month), respectively.

More news about Inovio Pharmaceuticals.


Please enter your comment!
Please enter your name here